Ville K Äijälä, Päivi Sirniö, Henna Karjalainen, Meeri Kastinen, Vilja V Tapiainen, Hanna Elomaa, Maarit Ahtiainen, Vesa-Matti Pohjanen, Taneli T Mattila, Outi Lindgren, Olli Helminen, Erkki-Ville Wirta, Jukka Rintala, Sanna Meriläinen, Juha Saarnio, Tero Rautio, Toni T Seppälä, Jan Böhm, Jukka-Pekka Mecklin, Anne Tuomisto, Markus J Mäkinen, Juha P Väyrynen
{"title":"结直肠癌肿瘤萌芽的距离评价。","authors":"Ville K Äijälä, Päivi Sirniö, Henna Karjalainen, Meeri Kastinen, Vilja V Tapiainen, Hanna Elomaa, Maarit Ahtiainen, Vesa-Matti Pohjanen, Taneli T Mattila, Outi Lindgren, Olli Helminen, Erkki-Ville Wirta, Jukka Rintala, Sanna Meriläinen, Juha Saarnio, Tero Rautio, Toni T Seppälä, Jan Böhm, Jukka-Pekka Mecklin, Anne Tuomisto, Markus J Mäkinen, Juha P Väyrynen","doi":"10.1007/s00428-026-04471-9","DOIUrl":null,"url":null,"abstract":"<p><p>Tumor budding is an established adverse prognostic factor in colorectal cancer (CRC), based on the number of isolated single tumor cells or small tumor cell clusters at the invasive front. While bud counts are well studied, the prognostic significance of the spatial distribution and distance of tumor buds away from the tumor bulk is unclear. We defined TB-distance as the average distance from the tumor bulk to the three farthest tumor buds and evaluated its clinicopathologic and prognostic associations in two independent CRC cohorts (N = 776 and N = 1,100). Using a cohort-derived cutoff, high TB-distance (≥ 123 µm) was significantly associated with adverse tumor characteristics, including high grade, advanced disease stage, lymphovascular invasion, high conventional tumor budding grade, and MMR proficient status (p < 0.003 for all). High TB-distance was also associated with shorter cancer-specific survival (Cohort 1: multivariable HR (high vs. low) 1.47, 95% CI 1.04-2.09, p = 0.030; Cohort 2: multivariable HR 1.34 95% CI 1.04-1.74, p = 0.026). However, TB-distance did not provide additional prognostic information within conventional tumor budding grade strata or when modeled alongside tumor budding. These findings indicate that high TB-distance is associated with aggressive tumor morphology and worse outcome but does not improve prognostication beyond standard tumor budding assessment. TB-distance may still be useful as a visual aid in routine pathology and a quantifiable spatial feature for computational pathology.</p>","PeriodicalId":23514,"journal":{"name":"Virchows Archiv","volume":" ","pages":"887-895"},"PeriodicalIF":3.0000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Distance-based evaluation of tumor budding in colorectal cancer.\",\"authors\":\"Ville K Äijälä, Päivi Sirniö, Henna Karjalainen, Meeri Kastinen, Vilja V Tapiainen, Hanna Elomaa, Maarit Ahtiainen, Vesa-Matti Pohjanen, Taneli T Mattila, Outi Lindgren, Olli Helminen, Erkki-Ville Wirta, Jukka Rintala, Sanna Meriläinen, Juha Saarnio, Tero Rautio, Toni T Seppälä, Jan Böhm, Jukka-Pekka Mecklin, Anne Tuomisto, Markus J Mäkinen, Juha P Väyrynen\",\"doi\":\"10.1007/s00428-026-04471-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Tumor budding is an established adverse prognostic factor in colorectal cancer (CRC), based on the number of isolated single tumor cells or small tumor cell clusters at the invasive front. While bud counts are well studied, the prognostic significance of the spatial distribution and distance of tumor buds away from the tumor bulk is unclear. We defined TB-distance as the average distance from the tumor bulk to the three farthest tumor buds and evaluated its clinicopathologic and prognostic associations in two independent CRC cohorts (N = 776 and N = 1,100). Using a cohort-derived cutoff, high TB-distance (≥ 123 µm) was significantly associated with adverse tumor characteristics, including high grade, advanced disease stage, lymphovascular invasion, high conventional tumor budding grade, and MMR proficient status (p < 0.003 for all). High TB-distance was also associated with shorter cancer-specific survival (Cohort 1: multivariable HR (high vs. low) 1.47, 95% CI 1.04-2.09, p = 0.030; Cohort 2: multivariable HR 1.34 95% CI 1.04-1.74, p = 0.026). However, TB-distance did not provide additional prognostic information within conventional tumor budding grade strata or when modeled alongside tumor budding. These findings indicate that high TB-distance is associated with aggressive tumor morphology and worse outcome but does not improve prognostication beyond standard tumor budding assessment. TB-distance may still be useful as a visual aid in routine pathology and a quantifiable spatial feature for computational pathology.</p>\",\"PeriodicalId\":23514,\"journal\":{\"name\":\"Virchows Archiv\",\"volume\":\" \",\"pages\":\"887-895\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2026-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Virchows Archiv\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00428-026-04471-9\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/3/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virchows Archiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00428-026-04471-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
Distance-based evaluation of tumor budding in colorectal cancer.
Tumor budding is an established adverse prognostic factor in colorectal cancer (CRC), based on the number of isolated single tumor cells or small tumor cell clusters at the invasive front. While bud counts are well studied, the prognostic significance of the spatial distribution and distance of tumor buds away from the tumor bulk is unclear. We defined TB-distance as the average distance from the tumor bulk to the three farthest tumor buds and evaluated its clinicopathologic and prognostic associations in two independent CRC cohorts (N = 776 and N = 1,100). Using a cohort-derived cutoff, high TB-distance (≥ 123 µm) was significantly associated with adverse tumor characteristics, including high grade, advanced disease stage, lymphovascular invasion, high conventional tumor budding grade, and MMR proficient status (p < 0.003 for all). High TB-distance was also associated with shorter cancer-specific survival (Cohort 1: multivariable HR (high vs. low) 1.47, 95% CI 1.04-2.09, p = 0.030; Cohort 2: multivariable HR 1.34 95% CI 1.04-1.74, p = 0.026). However, TB-distance did not provide additional prognostic information within conventional tumor budding grade strata or when modeled alongside tumor budding. These findings indicate that high TB-distance is associated with aggressive tumor morphology and worse outcome but does not improve prognostication beyond standard tumor budding assessment. TB-distance may still be useful as a visual aid in routine pathology and a quantifiable spatial feature for computational pathology.
期刊介绍:
Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.